These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8970763)

  • 1. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.
    Panahloo A; Yudkin JS
    Coron Artery Dis; 1996 Oct; 7(10):723-31. PubMed ID: 8970763
    [No Abstract]   [Full Text] [Related]  

  • 2. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.
    Panahloo A; Yudkin JS
    J Cardiovasc Risk; 1997 Apr; 4(2):91-9. PubMed ID: 9304490
    [No Abstract]   [Full Text] [Related]  

  • 3. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients.
    Schneider DJ; Nordt TK; Sobel BE
    Diabetes; 1993 Jan; 42(1):1-7. PubMed ID: 8420806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.
    Nordt TK; Schneider DJ; Sobel BE
    Circulation; 1994 Jan; 89(1):321-30. PubMed ID: 8281664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.
    Morale M; De Negri F; Carmassi F
    Diabetologia; 1997 Jun; 40(6):735-7. PubMed ID: 9222656
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen, fibrinolysis and diabetes mellitus: a comment.
    Vague P; Juhan-Vague I
    Diabetologia; 1997 Jun; 40(6):738-40. PubMed ID: 9222657
    [No Abstract]   [Full Text] [Related]  

  • 7. Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes.
    Trost S; Pratley R; Sobel B
    Curr Diab Rep; 2006 Feb; 6(1):47-54. PubMed ID: 16522281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up.
    Rautio A; Boman K; Eriksson JW; Svensson MK
    Diab Vasc Dis Res; 2016 May; 13(3):183-91. PubMed ID: 26818227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function, coagulopathy, and impaired fibrinolysis in diabetes.
    Sobel BE; Schneider DJ
    Cardiol Clin; 2004 Nov; 22(4):511-26. PubMed ID: 15501620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus.
    Skrha J; Sindelka G; Kvasnicka J; Hilgertová J
    Diabetes Res Clin Pract; 1999 Apr; 44(1):27-33. PubMed ID: 10414937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study.
    Davidson M; Zhu J; Lu W; Tracy RP; Robbins DC; Resnick HE; Ruotolo G; Howard BV;
    Diabet Med; 2006 Oct; 23(10):1158-9. PubMed ID: 16978385
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients.
    McGill JB; Schneider DJ; Arfken CL; Lucore CL; Sobel BE
    Diabetes; 1994 Jan; 43(1):104-9. PubMed ID: 8262307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis.
    Fujii S; Goto D; Zaman T; Ishimori N; Watano K; Kaneko T; Okada H; Makiguchi M; Nakagawa T; Kitabatake A
    J Atheroscler Thromb; 1998; 5(2):76-81. PubMed ID: 10855561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding "Reference value of transcutaneous oxygen measurement in diabetic patients compared with nondiabetic patients".
    Jaquinandi V; Mahe G; Leftheriotis G; Saumet JL; Abraham P
    J Vasc Surg; 2009 Jan; 49(1):279-80; author reply 280-1. PubMed ID: 19174273
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity and vascular disease in insulin-dependent diabetics.
    Martin FI; Stocks AE
    Br Med J; 1968 Apr; 2(5597):81-2. PubMed ID: 5646096
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation profile in diabetes and its association with diabetic microvascular complications.
    Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
    J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
    Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
    Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
    Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.